Q3 2019 Roche Holding AG Corporate Sales Call Transcript
Ladies and gentlemen welcome to the Roche's Third Quarter 2019 Audio Webcast and Conference Call. I am Sharon, your Chorus Call operator. (Operator Instructions) And the conference is being recorded. (Operator Instructions) The conference must not be recorded for publication or broadcast.
At this time, it's my pleasure to hand over to Dr. Severin Schwan, CEO of Roche Group. Please go ahead.
Thank you. And welcome, everybody, for -- and thank you for joining our Q3 briefing.
If we turn right to Slide 6. We have seen strong results in Q3 with 12% growth in Pharma, very much driven by the newly launched medicines; and 4% growth in diagnostics, actually accelerating in the third quarter, very much driven by Immunodiagnostics. So on a Roche Group level, year-to-date, 10% growth, 13% on a quarterly basis. And if you look at it into regional -- from a regional perspective, really all regions contributing to this result. Very much Pharma, of course, as in previous quarters. International
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
